A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMT

NCT03866109 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: Temferon

Sponsor

Genenta Science